These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 95233)

  • 1. Central serotonin metabolism and frequency of depression.
    van Praag HM; de Haan S
    Psychiatry Res; 1979 Dec; 1(3):219-24. PubMed ID: 95233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression vulnerability and 5-hydroxytryptophan prophylaxis.
    van Praag H; de Hann S
    Psychiatry Res; 1980 Sep; 3(1):75-83. PubMed ID: 6160599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprophylaxis of depressions. An attempt to compare lithium with 5-hydroxytryptophan.
    van Praag HM; de Haan S
    Acta Psychiatr Scand Suppl; 1981; 290():191-201. PubMed ID: 6164250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Harold E. Himwich Memorial Lecture. Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders.
    Praag HM
    Biol Psychiatry; 1977 Feb; 12(1):101-31. PubMed ID: 300032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and Parkinson's disease: possible role of serotonergic mechanisms.
    Kostić VS; Djuricić BM; Covicković-Sternić N; Bumbasirević L; Nikolić M; Mrsulja BB
    J Neurol; 1987 Feb; 234(2):94-6. PubMed ID: 2435855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affective disorders and aggression disorders: evidence for a common biological mechanism.
    van Praag HM
    Suicide Life Threat Behav; 1986; 16(2):103-32. PubMed ID: 2428139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic indications for serotonin-potentiating compounds: a hypothesis.
    van Praag HM; Kahn R; Asnis GM; Lemus CZ; Brown SL
    Biol Psychiatry; 1987 Feb; 22(2):205-12. PubMed ID: 2434148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxytryptophan-induced cortisol response and CSF 5-HIAA in depressed patients.
    Koyama T; Lowy MT; Meltzer HY
    Am J Psychiatry; 1987 Mar; 144(3):334-7. PubMed ID: 2435178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J; Vanderheyden JE; Noel G
    Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression, suicide and the metabolism of serotonin in the brain.
    Van Praag HM
    J Affect Disord; 1982 Dec; 4(4):275-90. PubMed ID: 6186712
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of depression with serotonin precursors.
    van Praag HM
    Biol Psychiatry; 1981 Mar; 16(3):291-310. PubMed ID: 6164407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.
    Goodwin FK; Post RM
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):393S-405S. PubMed ID: 6190490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotoninergic depression--hypothesis or reality?].
    Leboyer M; Plaisant O
    Encephale; 1983; 9(4):317-30. PubMed ID: 6200312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients.
    Katz MM; Maas JW; Frazer A; Koslow SH; Bowden CL; Berman N; Swann AC; Stokes PE
    Neuropsychopharmacology; 1994 Oct; 11(2):89-100. PubMed ID: 7530963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the tryptophan-serotonin metabolism in manic-depressive disorders. Changes in plasma 5-HT and 5-HIAA levels and urinary 5-HIAA excretion following oral loading of L-5HTP in patients with depression.
    Amamoto T; Sarai K
    Hiroshima J Med Sci; 1976 Sep; 25(2-3):135-40. PubMed ID: 1088369
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin concentrations and turnover in brains of depressed suicides.
    Cheetham SC; Crompton MR; Czudek C; Horton RW; Katona CL; Reynolds GP
    Brain Res; 1989 Nov; 502(2):332-40. PubMed ID: 2479456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
    Byerley WF; Risch SC
    J Clin Psychopharmacol; 1985 Aug; 5(4):191-206. PubMed ID: 2410463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Auto)aggression and serotonin. A review of human data.
    De Cuyper H
    Acta Psychiatr Belg; 1987; 87(3):325-31. PubMed ID: 2445174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary excretion of 5-hydroxyindoleacetic acid and serum tryptophan and serotonin levels in patients with depression].
    Pietruszewska I; Jasińska M; Lewicka-Wysocka H; Marcjan K; Stencka K
    Psychiatr Pol; 1984; 18(1):9-16. PubMed ID: 6204348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.